Prevention and treatment of peri-implant diseases-The EFP S3 level clinical practice guideline.
View/ Open
Volume
50 Suppl 26
Pagination
4 - 76
DOI
10.1111/jcpe.13823
Journal
J Clin Periodontol
Metadata
Show full item recordAbstract
BACKGROUND: The recently published Clinical Practice Guidelines (CPGs) for the treatment of stages I-IV periodontitis provided evidence-based recommendations for treating periodontitis patients, defined according to the 2018 classification. Peri-implant diseases were also re-defined in the 2018 classification. It is well established that both peri-implant mucositis and peri-implantitis are highly prevalent. In addition, peri-implantitis is particularly challenging to manage and is accompanied by significant morbidity. AIM: To develop an S3 level CPG for the prevention and treatment of peri-implant diseases, focusing on the implementation of interdisciplinary approaches required to prevent the development of peri-implant diseases or their recurrence, and to treat/rehabilitate patients with dental implants following the development of peri-implant diseases. MATERIALS AND METHODS: This S3 level CPG was developed by the European Federation of Periodontology, following methodological guidance from the Association of Scientific Medical Societies in Germany and the Grading of Recommendations Assessment, Development and Evaluation process. A rigorous and transparent process included synthesis of relevant research in 13 specifically commissioned systematic reviews, evaluation of the quality and strength of evidence, formulation of specific recommendations, and a structured consensus process involving leading experts and a broad base of stakeholders. RESULTS: The S3 level CPG for the prevention and treatment of peri-implant diseases culminated in the recommendation for implementation of various different interventions before, during and after implant placement/loading. Prevention of peri-implant diseases should commence when dental implants are planned, surgically placed and prosthetically loaded. Once the implants are loaded and in function, a supportive peri-implant care programme should be structured, including periodical assessment of peri-implant tissue health. If peri-implant mucositis or peri-implantitis are detected, appropriate treatments for their management must be rendered. CONCLUSION: The present S3 level CPG informs clinical practice, health systems, policymakers and, indirectly, the public on the available and most effective modalities to maintain healthy peri-implant tissues, and to manage peri-implant diseases, according to the available evidence at the time of publication.
Authors
Herrera, D; Berglundh, T; Schwarz, F; Chapple, I; Jepsen, S; Sculean, A; Kebschull, M; Papapanou, PN; Tonetti, MS; Sanz, MCollections
Language
Licence information
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States
Related items
Showing items related by title, author, creator and subject.
-
Oral Microcosm Biofilms Grown under Conditions Progressing from Peri-Implant Health, Peri-Implant Mucositis, and Peri-Implantitis
Sousa, V; Spratt, D; Davrandi, M; Mardas, N; Beltran, V; Donos, N (MDPI, 2022-10-28) -
The effect of a 2-mm inter-implant distance on esthetic outcomes in immediately non-occlusally loaded platform shifted implants in healed ridges: 12-month results of a randomized clinical trial
Rivara, F; Macaluso, GM; Toffoli, A; Calciolari, E; Goldoni, M; Lumetti, S (2020-08) -
Targeted Peri-implant Crevicular Fluid Biomarkers in Osteoporotic Patients Receiving a Dental Implant
Sharifi, A (Queen Mary University of London, 2023)Aims and Objectives: The aim of this pilot study was to describe the protein expression during the early and late stage of osseointegration in the peri-implant crevicular fluid (PICF) of a cohort of post-menopausal ...